US Drug Recall Register
Class II · Moderate risk Terminated Initiated Jun 6, 2012 (14 years ago)

Diazepam Injection

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Impurities/Degradation Products: High Out of Specification levels for carbostyril, a known degradation product of diazepam.

What was recalled

Diazepam Injection, USP, 10 mg Automatic, Autoinjector for Buddy Use, 5 mg/mL, 2 mL autoinjector, 15-count autoinjectors per carton, Rx only, Meridian Medical Technologies, Columbia, MD 21046; A subsidiary of King Pharmaceuticals, Inc.; NSN 6505-01-274-0951, NDC 11704-600-01.

Recalling firm
Meridian Medical Technologies a Pfizer Company
NDC code
11704-600-01
Origin
MO, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1369-2012

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Diazepam recalls

See all
Class II · Moderate risk Terminated

Diazepam Oral Solution

Reason Failed Impurities/Degradation Specifications: Out of specification results for related substances.

Lannett Company, Inc. NDC 0527-1768-36 D-0558-2022
Class III · Low risk Terminated

Diazepam Rectal Gel

Reason Labeling: Incorrect or Missing Lot and/or Exp Date: Product distributed without a lot number or expiration date on the outer carton.

Valeant Pharmaceuticals North America LLC NDC 68682-650-20 D-1041-2018
Class II · Moderate risk Terminated

Diazepam Injection USP 10mg/2mL

Reason Crystallization: Product contains particulate identified to be crystallized active ingredient.

Hospira Inc. NDC 0409-1273-32 D-1359-2016
Class II · Moderate risk Terminated

Diazepam 5 mg/mL injectable packaged in an amber glass injectable vial

Reason Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.

Martin Avenue Pharmacy, Inc. D-0078-2015